SKAI X Inc.

🧠 SKAI X Inc: Seeing the Future of Healthcare Through Your Eyes SKAI X is an AI-powered medical intelligence company revolutionizing diagnostics by turning eye scans into powerful predictors of systemic health. 🔍 What We Do: We combine multi-modal fundus imaging (CFI, UFI, OCT) with optimized AI models to: Detect 10+ eye diseases (DR, Glaucoma, AMD, etc.) with ~99% accuracy Predict 30+ biomarkers (e.g., glucose, cholesterol, BMI, BP) within ~5% clinical difference Assess stroke and cardiovascular risks using proprietary indicators like the Global Tortuosity Index (GTI) 💼 Our Products: SKAI Eyes: Real-time eye disease detection with heatmap-based explainability SKAI Biomarkers: One-shot prediction of systemic health from retinal scans SKAI Brains: Stroke and vascular risk stratification (R&D-backed with $2M grant) 🚀 Why Partner With Us? Clinically validated with top hospitals (Samsung Medical Center, Ajou University, SNUH) 95–99% diagnostic accuracy, 10% higher biomarker precision than traditional labs 📈 Backed by a Global Market Surge: $445M addressable Medical AI Eye segment 47% CAGR (2024–2027) PACS & imaging integration with Zeiss, Canon, Nidek, Optomed, and more 🧬 Our Edge: Multi-scale, multi-modal, and multi-task learning Textual symptom outputs, standardized RoIs, and AI heatmaps for interpretability Seamless deployment in clinical workflows with plug-and-play AI engines

• Employees 3